Drug Database
Back to search

United States· US:70518-4393_3a0ce845-ca16-a1f1-e063-6294a90ab259

Dicyclomine Hydrochloride

A dicycloverine product containing dicyclomine hydrochloride, registered in United States by REMEDYREPACK INC.. The same ATC class is registered in 3 of our 19 countries.

ATC A03AA07US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDicyclomine HydrochlorideATCA03AA07REGISTER NO.US:70518-4393_3a0ce84…PACKS LISTED2CHECKEDSeptember 6, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dicyclomine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dicycloverine is registered in 3 of 19 countries.

Countries holding a registration under ATC A03AA07 (dicycloverine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 1 of them publish a price we can compare per daily dose
Search dicycloverine products by name

Dicycloverine · ATC A03AA07

3 / 19 countries

  • Canada
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dicycloverine costs, country by country.

Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.

  • United States: $0.62 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Dicycloverine · price per daily dose (80 mg)

USD · FX 28 Sept 2026

  • US United States$0.62 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DICYCLOMINE HYDROCHLORIDE
Manufacturer
REMEDYREPACK INC.
Country
United States (US)
ATC code
A03AA07
ATC class
Dicycloverine
Defined daily dose
80 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 6, 2026

Packs & prices · 2

  • ndc11
    7051843930
    30 TABLET in 1 BLISTER PACK (70518-4393-0)
  • ndc11
    70518-4393-0

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

389 interactions on record for dicycloverine.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dicycloverine against other medicinesHow interaction checks work

Dicycloverine · interactions on record

389 records

  • 6 severe
  • 194 moderate
  • 17 minor
  • 172 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • TopiramatN02CX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dicycloverine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dicycloverine products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Dicycloverine, Dicycloverine Focus Pharmaceuticals
  • Latvia · Trigan-Sp

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e34a79c1-1e16-4a12-bae5-759259752f05
GET /v1/drugs/e34a79c1-1e16-4a12-bae5-759259752f05?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "20",
  "substance": "DICYCLOMINE HYDROCHLORIDE",
  "productndc": "70518-4393",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA040317",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about dicycloverine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console